BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 8692115)

  • 1. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
    Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Second marrow transplantation following high dose busulfan, etoposide, and Ara-C after testicular relapse in a patient with AML].
    Matsue K; Tohi T; Masauji N; Tsukuda K
    Rinsho Ketsueki; 1992 Mar; 33(3):338-42. PubMed ID: 1578638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
    Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies--matched pair analysis].
    Creutzig U; Bender-Götze C; Klingebiel T; Ebell W; Friedrich W; Stollmann-Gibbels B; Schmidt H; Suttorp M; Gratwohl A; Heyen P
    Klin Padiatr; 1992; 204(4):246-52. PubMed ID: 1518260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children].
    Ortega Aramburu JJ; Olivé Oliveras T; Javier Manchón G; Bastida Vila P; Sánchez C; Giralt López J
    Sangre (Barc); 1991 Feb; 36(1):7-14. PubMed ID: 1853274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM; Grañena A; Rozman C; Urbano-Ispizua A; Bladé J; Carreras E; Cervantes F; Marín P; Sierra J; Nomdedeu B
    Sangre (Barc); 1990 Feb; 35(1):26-32. PubMed ID: 2333581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AML.
    Harousseau JL; Pignon B; Dufour P; Ifrah N; Solary E; Abgrall JF; Milpied N; Desablens B; Guyotat D; Herve P
    Leukemia; 1992; 6 Suppl 2():120-3. PubMed ID: 1578912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double intensification with amsacrine/high dose ara-C and high dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemia.
    Spinolo JA; Dicke KA; Horwitz LJ; Jagannath S; Zander AR; Auber ML; Spitzer G
    Bone Marrow Transplant; 1990 Feb; 5(2):111-8. PubMed ID: 1690035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
    Hansen OP; Pedersen-Bjergaard J; Ellegaard J; Brincker H; Boesen AM; Christensen BE; Drivsholm A; Hippe E; Jans H; Jensen KB
    Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of acute lymphatic leukemia in adults: pilot project with intensive early therapy without a maintenance phase].
    Wernli M; Gratwohl A; von Fliedner V; Tichelli A; Clément F; Grob JP; Chapuis B; Maurice P; Brun del Re G; Fey MF
    Schweiz Med Wochenschr; 1991 Feb; 121(6):194-8. PubMed ID: 2008599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group].
    Creutzig U; Ritter J; Heyen P; Berthold F; Henze G; Kabisch H; Lampert F; Niethammer D; Riehm H; Schellong G
    Klin Padiatr; 1992; 204(4):236-45. PubMed ID: 1518259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of acute myeloid leukemia in children--results of the AML II/87 multicenter study].
    Hermann J; Zintl F; Krause M; Palme H; Fuchs D; Prager J; Dörffel W; Domula M; Eggers G; Exadaktylos P
    Kinderarztl Prax; 1991 Nov; 59(11):321-7. PubMed ID: 1758135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remission.
    Ferrant A; Doyen C; Delannoy A; Cornu G; Martiat P; Latinne D; De Bruyère M; Bosly A; Michaux JL; Sokal G
    Bone Marrow Transplant; 1991 Apr; 7(4):303-9. PubMed ID: 2070137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive individualized induction therapy with behenoyl cytarabine, daunorubicin and 6-mercaptopurine followed by intensive consolidation including intermediate-dose continuous cytarabine, mitoxantron, etoposide and vinca alkaloids in acute myeloid leukemia in adults.
    Ohno R; Yokomaku S; Okumura M; Nagai T; Kitaori K; Ito T; Takeo T; Sugiura I; Yano K; Ito Y
    Int J Hematol; 1991 Dec; 54(6):487-93. PubMed ID: 1793832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.
    Cassileth PA; Andersen JW; Bennett JM; Harrington DP; Hines JD; Lazarus HM; Mazza JJ; McGlave PP; O'Connell MJ; Paietta E
    Leukemia; 1992; 6 Suppl 2():116-9. PubMed ID: 1578910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for postremission treatment in childhood acute myeloid leukemia (AML). The AIEOP experience 1987-1991.
    Amadori S; Giona F; Giuliano M; Moleti ML; Pession A; Rolla M; Rondelli R; Testi AM; Mandelli F
    Leukemia; 1992; 6 Suppl 2():44-7. PubMed ID: 1578940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term therapy (STT) for acute myelogenous leukaemia (AML).
    Rohatiner AZ; Battista R; Bassan R; Love S; Oza AM; Whelan JS; Lim J; Buelli M; Viero P; D'Emillio A
    Leukemia; 1992; 6 Suppl 2():85-8. PubMed ID: 1578952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of the treatment of acute nonlymphoblastic leukemias in children (1968-1990)].
    Ortega Aramburu JJ; Olive Oliveras T; Javier Manchón G; Bastida Vila P
    An Esp Pediatr; 1991 Sep; 35(3):157-63. PubMed ID: 1741570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients.
    Cahn JY; Bordigoni P; Souillet G; Pico JL; Plouvier E; Reiffers J; Benz-Lemoine E; Bergerat JP; Lutz P; Colombat P
    Bone Marrow Transplant; 1991 Jan; 7(1):1-4. PubMed ID: 2043871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of postremission chemotherapy for adults with acute myeloid leukemia using different dose-intensities.
    Jehn U
    Leuk Lymphoma; 1994 Sep; 15(1-2):99-112. PubMed ID: 7532060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.